Loading...
XNAS
MASS
Market cap240mUSD
Dec 04, Last price  
6.65USD
1D
6.91%
1Q
22.24%
IPO
-86.83%
Name

908 Devices Inc.

Chart & Performance

D1W1MN
XNAS:MASS chart
P/E
—
P/S
4.04
EPS
—
Div Yield, %
—
Shrs. gr., 5y
5.40%
Rev. gr., 5y
27.11%
Revenues
60m
+18.72%
22,054,00017,972,00026,894,00042,206,00046,852,00050,229,00059,631,000
Net income
-72m
L+98.37%
-7,536,000-15,204,000-6,936,000-22,116,000-31,744,000-36,399,000-72,206,000
CFO
-30m
L+20.70%
-8,898,000-11,004,0004,131,000-29,082,000-20,930,000-25,059,000-30,247,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
URL
https://908devices.com/
IPO date
Dec 18, 2020
Employees
227
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT